Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Sales

Tonix Pharmaceuticals Holding (TNXP) Return on Capital Employed (2024 - 2025)

Historic Return on Capital Employed for Tonix Pharmaceuticals Holding (TNXP) over the last 2 years, with Q3 2025 value amounting to 0.5%.

  • Tonix Pharmaceuticals Holding's Return on Capital Employed rose 16000.0% to 0.5% in Q3 2025 from the same period last year, while for Sep 2025 it was 0.5%, marking a year-over-year increase of 16000.0%. This contributed to the annual value of 0.97% for FY2024, which is N/A changed from last year.
  • As of Q3 2025, Tonix Pharmaceuticals Holding's Return on Capital Employed stood at 0.5%, which was up 16000.0% from 0.48% recorded in Q2 2025.
  • Tonix Pharmaceuticals Holding's 5-year Return on Capital Employed high stood at 0.48% for Q2 2025, and its period low was 2.1% during Q3 2024.